Skip to main content

User account menu

  • My EPI-CE Documentation
  • Log in

Top navigation

  • GSA Award
  • For Veterans
  • HCP Portal
  • Pay My Bill Online
  • Contact Us
  • +49 89 416 17270
ExosomeDx logo

User account menu

  • My EPI-CE Documentation
  • Log in

Main navigation

  • Physicians
    • How to Order the ExoDx™ Prostate Test
    • ExoDx™ Prostate Test: At-Home Collection Kit
    • ExoDx™ Prostate Test
    • Challenge of Prostate Cancer
    • Physician FAQs
    • What are Exosomes
    • Publications and Abstracts
    • mpMRI + ExoDx Prostate Test
  • Patients
    • The ExoDx Prostate Test
    • How to Order the ExoDx™ Prostate Test
    • Physician Finder
    • Understanding PSA Levels
    • Elevated PSA Levels
    • Normal PSA Levels & PSA Levels by Age
    • About Prostate Cancer
    • ZERO - The End of Prostate Cancer
    • Patient FAQs
    • ExoCARES Program
  • Our Technology
    • Our Technology
    • Sensitivity to RNA/DNA
    • Extraction Procedures
    • Superiority to cfDNA and CTCs
  • News & Resources
    • Literature
    • Press
    • Webinars
    • Events
    • Newsletters

Top navigation

  • GSA Award
  • For Veterans
  • HCP Portal
  • Pay My Bill Online
  • Contact Us
  • +49 89 416 17270

ExosomeDx Webinars & Urology Resources

  • Learn About Research and Clinical Applications of Exosome Based Liquid Biopsies

    Webinar Nov 13, 2019

    Listen as Dr. Skog breaks down the science behind exosome-based liquid-biopsies and how they can be used to address diagnostic uncertainty in the field of prostate cancer.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Page 2
  • Current page 3

(844) 396-7663
exodx@mdxhealth.com 
266 Second Ave, Suite 200
Waltham, MA 02451

Footer menu

  • About
  • Careers
  • Investors
  • Accreditation and Licensure

Social navigation

  • Facebook
  • Twitter
  • LinkedIn

The ExoDx Prostate Test was evaluated and its performance characteristics determined by Exosome Diagnostics, Inc. Exosome Diagnostics is certified under the Clinical Laboratory Improvement Amendments (CLIA) Act of 1988 as qualified to perform high complexity clinical testing. CLIA number: 22D2093470.  Exosome Diagnostics and ExoDx are registered trademarks of Exosome Diagnostics, Inc.

© 2026 ExoDx

Bottom footer navigation

  • Privacy Policy